PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-59.37%
Negative revenue growth while MTDR stands at 23.71%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-86.14%
Negative gross profit growth while MTDR is at 23.93%. Joel Greenblatt would examine cost competitiveness or demand decline.
-763.74%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-763.74%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12450.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10160.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-10160.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.27%
OCF growth under 50% of MTDR's 808.37%. Michael Burry might suspect questionable revenue recognition or rising costs.
67.00%
FCF growth above 1.5x MTDR's 20.94%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-48.13%
Negative 10Y revenue/share CAGR while MTDR stands at 270.36%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-85.70%
Negative 5Y CAGR while MTDR stands at 270.36%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-80.18%
Negative 3Y CAGR while MTDR stands at 270.36%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
73.40%
10Y OCF/share CAGR above 1.5x MTDR's 45.85%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-68.02%
Negative 5Y OCF/share CAGR while MTDR is at 45.85%. Joel Greenblatt would question the firm’s operational model or cost structure.
-67.08%
Negative 3Y OCF/share CAGR while MTDR stands at 45.85%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-716.99%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-212.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-732.46%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
0.18%
Equity/share CAGR of 0.18% while MTDR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-59.22%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-71.24%
Negative 3Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
397.82%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
7.00%
Stable or rising mid-term dividends while MTDR is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-50.19%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
0.50%
Our AR growth while MTDR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-13.56%
Negative asset growth while MTDR invests at 8.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.31%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.20%
We’re deleveraging while MTDR stands at 300.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.86%
We cut SG&A while MTDR invests at 8.01%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.